Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
REVIEWS
Open Access
oa
Current development of chimeric antigen receptor T-cell therapy for diffuse large B-cell lymphoma and high-grade B-cell lymphoma
- Pages: 662-677
- First Published: 03 January 2024
Open Access
oa
Recombinant factor IX Fc for the treatment of hemophilia B
- Pages: 678-691
- First Published: 18 February 2024
ORIGINAL ARTICLES
no
Enhancing thalassemia gene carrier identification in non-anemic populations using artificial intelligence erythrocyte morphology analysis and machine learning
- Pages: 692-700
- First Published: 28 December 2023
Open Access
oa
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain
- Pages: 701-713
- First Published: 25 December 2023
no
Delayed diagnostic interval and survival outcomes in pediatric leukemia: A single-center, retrospective study
- Pages: 714-722
- First Published: 28 December 2023
no
Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system
- Pages: 723-730
- First Published: 28 December 2023
Open Access
oa
Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
- Pages: 731-742
- First Published: 08 January 2024
no
Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
- Pages: 743-755
- First Published: 28 December 2023
Open Access
oa
A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A
- Pages: 756-764
- First Published: 09 January 2024
Open Access
oa
Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study
- Pages: 765-775
- First Published: 15 January 2024
Open Access
oa
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms
- Pages: 776-787
- First Published: 16 January 2024
Open Access
oa
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia
- Pages: 788-793
- First Published: 04 February 2024
Open Access
oa
Soluble mannose receptor: A potential biomarker in Gaucher disease
- Pages: 794-801
- First Published: 10 January 2024
Open Access
oa
Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade
- Pages: 802-809
- First Published: 06 January 2024
no
Comparison of telomere length in patients with bone marrow failure syndromes and healthy controls
- Pages: 810-818
- First Published: 12 January 2024
Open Access
oa
Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections
- Pages: 819-831
- First Published: 20 January 2024
Open Access
oa
The applicability of the central line-associated bloodstream infection (CLABSI) criteria for the evaluation of bacteremia episodes in pediatric oncology patients
- Pages: 832-839
- First Published: 31 January 2024
no
Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients
- Pages: 840-844
- First Published: 02 February 2024